北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学临床研究所  > 期刊论文
学科主题: 临床医学
题名:
Factors associated with compliance to lipid-lowering treatment in China
作者: Xie, Gaoqiang1; Zaman, M. Justin S.2,3,4; Myint, Phyo K.4,5; Liang, Lirong6; Zhao, Liancheng7,8; Wu, Yangfeng1,9
关键词: Compliance ; dyslipidaemia ; lipid-lowering therapy ; cardiovascular disease
刊名: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
发表日期: 2013-04-01
DOI: 10.1177/2047487312438847
卷: 20, 期:2, 页:229-237
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Cardiac & Cardiovascular Systems
研究领域[WOS]: Cardiovascular System & Cardiology
关键词[WOS]: CORONARY-HEART-DISEASE ; TREATMENT PANEL-III ; CHOLESTEROL LEVELS ; STATIN THERAPY ; POPULATION ; PREVENTION ; ADHERENCE ; EDUCATION ; HEALTH ; DYSLIPIDEMIA
英文摘要:

Background: There are an estimated 200 million people in China with dyslipidaemia. We sought to explore factors that influence compliance to treatment of dyslipidaemia, using a multi-centre sample in China.

Methods: Through review of medical notes and direct interviews at two points in time (2006 and 2007) of 2094 patients in 27 hospitals receiving lipid-lowering therapy since 2004, 1890 patients were recruited who had been on treatment for more than one year. Good compliance (GC) was defined as days taking lipid-lowering drugs/total days of follow-up >= 80%. Logistic regression models were used to assess factors associated with GC.

Results: In patients with one, two and three years of treatment respectively, GC was greater in those with higher versus lower medical insurance cover - odds ratios 2.8 (95%CI 2.2-3.7), 2.0 (1.5-2.7), 4.3 (2.3-8.1); in patients in province-level versus county-level hospitals-2.0 (1.5-2.6), 2.9 (2.0-4.1), 4.6 (1.8-12.0); in patients treated by non-cardiology physicians compared to cardiologists -1.7 (1.1-2.5), 2.0 (1.3-3.0), 4.0 (1.5-10.3) and in patients using a statin versus other forms of medication for dyslipidaemia -1.7 (1.2-2.2), 1.7 (1.2-2.3), 4.4 (2.3-8.5).

Conclusions: Better medical insurance cover, care in a province-level hospital rather than county-level hospital, treatment by a non-cardiologist and use of a statin were associated with better compliance to lipid-lowering treatment.

语种: 英语
项目资助者: Schering-Plough China Corp ; Merck Sharp &amp ; Dohme China Corp
WOS记录号: WOS:000318876700005
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/50837
Appears in Collections:北京大学临床研究所_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.James Paget Univ Hosp, Dept Cardiol, Great Yarmouth, England
2.George Inst, Beijing, Peoples R China
3.Peking Univ, Clin Res Inst, Beijing 100871, Peoples R China
4.George Inst Global Hlth, Div Cardiovasc, Sydney, NSW, Australia
5.Univ E Anglia, Fac Med & Hlth Sci, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England
6.Univ Cambridge, Dept Publ Hlth & Primary Care, Clin Gerontol Unit, Cambridge, England
7.Capital Med Univ, Beijing Chao Yang Hosp, Beijing, Peoples R China
8.Peking Union Med Coll, Fuwai Hosp, Beijing 100021, Peoples R China
9.Chinese Acad Med Sci, Beijing 100730, Peoples R China

Recommended Citation:
Xie, Gaoqiang,Zaman, M. Justin S.,Myint, Phyo K.,et al. Factors associated with compliance to lipid-lowering treatment in China[J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY,2013,20(2):229-237.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Xie, Gaoqiang]'s Articles
[Zaman, M. Justin S.]'s Articles
[Myint, Phyo K.]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Xie, Gaoqiang]‘s Articles
[Zaman, M. Justin S.]‘s Articles
[Myint, Phyo K.]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace